Torcetrapib

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameTorcetrapib
Drug Alias Name托彻普torcetrapibtorcetrapibum托塞匹布托塞曲匹 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHDL-cholesterol stimulantsCholesteryl ester transfer protein inhibitors
TargetsHDL-cholesterolCholesteryl ester transfer protein
Therapy Area/IndicationsHypertriglyceridemiaHyperlipidemiasDyslipidemias +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[20] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaHyperlipidemiasDyslipidemias +[10] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG